Fulcrum Therapeutics's total assets for Q4 2025 were $366.28M, an increase of 70.48% from the previous quarter. FULC total liabilities were $17.28M for the fiscal quarter, a 4.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.